Tumor Exosome-Mimicking Iron Oxide Nanoparticles for Near Infrared-Responsive Drug Delivery
Source abstract
Abstract
Nanoparticles are effective in drug delivery due to the capacity of drug loading and passive targeting effect. However, the nanoparticles tend to be recognized by the mononuclear phagocyte system and cleared from the circulatory system. As an endogenous material, exosome is thermosensitive and can avoid the recognition of macrophages. Here, we developed tumor exosome-mimicking Fe3O4 nanoparticles for targeted drug delivery and photothermal therapy of cancer. The nanoparticles showed prominent biocompatibility and photothermal properties. Upon the irradiation of near-infrared light, the nanoparticles could release the drug rapidly and achieve a synergistic photothermal-chemotherapeutic effect.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China
College of Pharmaceutical Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China
Funding
National Natural Science Foundation of China · Zhenjiang City
References (36)
Show source-provided references
1. 10.1039/C7CS00522A10.1039/C7CS00522A ↗
2. 10.1002/anie.20191147710.1002/anie.201911477 ↗
3. 10.1039/D0BM01158D10.1039/D0BM01158D ↗
4. Riley R. · WIREs Nanomed Nanobiotechnol. · 2017 · 9 · 110.1002/wnan.1449 ↗
5. 10.1039/D0TB00240B10.1039/D0TB00240B ↗
6. 10.1016/j.jcis.2020.02.05110.1016/j.jcis.2020.02.051 ↗
7. 10.1039/D0TB01448F10.1039/D0TB01448F ↗
8. 10.1021/acs.molpharmaceut.6b0073210.1021/acs.molpharmaceut.6b00732 ↗
9. 10.1016/j.ijpharm.2014.08.02710.1016/j.ijpharm.2014.08.027 ↗
10. 10.1038/aps.2016.3710.1038/aps.2016.37 ↗
11. Wang Y. · Sci. Rep. · 2018 · 8 · 1
12. 10.1007/s11095-017-2165-810.1007/s11095-017-2165-8 ↗
13. 10.1016/j.ijpharm.2015.03.07010.1016/j.ijpharm.2015.03.070 ↗
14. Chen B. · Int. J. Nanomed. · 2009 · 4 · 25110.2147/IJN.S7932 ↗
15. 10.1021/acs.nanolett.9b0284110.1021/acs.nanolett.9b02841 ↗
16. Li M. · Nat. Commun. · 2020 · 11 · 110.1038/s41467-019-13993-7 ↗
17. Belhadj Z. · J Extracell Vesicles. · 2020 · 9 · 110.1080/20013078.2020.1806444 ↗
18. 10.1016/j.devcel.2019.04.01110.1016/j.devcel.2019.04.011 ↗
19. Tian R. · Front Bioeng Biotechnol. · 2020 · 8 · 110.3389/fbioe.2020.00001 ↗
20. Yan F. · J Nanobiotechnology. · 2020 · 18 · 110.1186/s12951-019-0560-5 ↗
21. 10.26355/eurrev_201806_1528010.26355/eurrev_201806_15280 ↗
22. 10.1038/nature2234110.1038/nature22341 ↗
23. 10.1016/j.jconrel.2016.01.00910.1016/j.jconrel.2016.01.009 ↗
24. 10.1021/acsnano.6b0760710.1021/acsnano.6b07607 ↗
25. 10.3109/13880209.2012.66593110.3109/13880209.2012.665931 ↗
26. 10.2147/IJN.S2546010.2147/IJN.S25460 ↗
27. 10.1039/c2nr33840h10.1039/c2nr33840h ↗
28. 10.1016/j.jddst.2020.10178210.1016/j.jddst.2020.101782 ↗
29. Kalimuthu S. · Front Pharmacol. · 2018 · 9 · 111610.3389/fphar.2018.01116 ↗
30. 10.3390/ma1315334410.3390/ma13153344 ↗
31. 10.1016/j.nano.2015.10.01210.1016/j.nano.2015.10.012 ↗
32. 10.1016/j.carbon.2016.02.07510.1016/j.carbon.2016.02.075 ↗
33. 10.1021/acs.nanolett.0c0014710.1021/acs.nanolett.0c00147 ↗
34. 10.1039/C8BM01672K10.1039/C8BM01672K ↗
35. 10.1021/nn901181c10.1021/nn901181c ↗
36. 10.1016/j.biomaterials.2018.11.03510.1016/j.biomaterials.2018.11.035 ↗